The usefulness of endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of pancreatic neuroendocrine tumors based on the World Health Organization classification

References

• O’Grady HL, Conlon KC. Pancreatic neuroendocrine tumours. Eur J Surg Oncol 2008;34:324–32.
   PubMed Web of Science ®Google Scholar
• Oberg K. Pancreatic endocrine tumors. Semin Oncol 2010;37:594–618.
   PubMed Web of Science ®Google Scholar
• Batcher E, Madaj P, Gianoukakis AG. Pancreatic neuroendocrine tumors. Endocr Res 2011;36:35–43.
   PubMed Web of Science ®Google Scholar
• Ito T, Tanaka M, Sasano H, Osamura YR, Sasaki I, Kimura W, et al. Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumors. J Gastroenterol 2007;42:497–500.
   PubMed Web of Science ®Google Scholar
• Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology 2008;135:1469–92.
   PubMed Web of Science ®Google Scholar
• Jani N, Khalid A, Kaushik N, Brody D, Bauer K, Schoedel K, et al. EUS-guided FNA diagnosis of pancreatic endocrine tumors: new trends identified. Gastrointest Endosc 2008;67:44–50.
   PubMed Web of Science ®Google Scholar
• Artale S, Giannetta L, Cerea G, Maggioni D, Pedrazzoli P, Schiavetto I, et al. Treatment of metastatic neuroendocrine carcinomas based on WHO classification. Anticancer Res 2005;25:4463–9.
   PubMed Web of Science ®Google Scholar
• Bajetta E, Catena L, Procopio G, Bichisao E, Ferrari L, Della Torre S, et al. Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment? Ann Oncol 2005;16:1374–80.
   PubMed Web of Science ®Google Scholar
• Plöckinger U, Rindi G, Arnold R, Eriksson B, Krenning EP, de Herder WW, et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 2004;80:394–424.
   PubMed Web of Science ®Google Scholar
• Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO Classification of tumours of the digestive system. Lyon: IARC Press; 2010.
   Google Scholar
• Rindi G, Klöppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006;449:395–401.
   PubMed Web of Science ®Google Scholar
• Klöppel G, Couvelard A, Perren A, Komminoth P, McNicol AM, Nilsson O, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology 2009;90:162–6.
   PubMed Web of Science ®Google Scholar
• Chang KJ, Nguyen P, Erickson RA, Durbin TE, Katz KD. The clinical utility of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic carcinoma. Gastrointest Endosc 1997;45:387–93.
   PubMed Web of Science ®Google Scholar
• Faigel DO, Ginsberg GG, Bentz JS, Gupta PK, Smith DB, Kochman ML. Endoscopic ultrasound-guided real-time fine-needle aspiration biopsy of the pancreas in cancer patients with pancreatic lesions. J Clin Oncol 1997;15:1439–43.
   PubMed Web of Science ®Google Scholar
• Gress FG, Hawes RH, Savides TJ, Ikenberry SO, Lehman GA. Endoscopic ultrasound-guided fine-needle aspiration biopsy using linear array and radial scanning endosonography. Gastrointest Endosc 1997;45:243–50.
   PubMed Web of Science ®Google Scholar
• Gress FG, Savides TJ, Sandler A, Kesler K, Conces D, Cummings O, et al. Endoscopic ultrasonography, fine-needle aspiration biopsy guided by endoscopic ultrasonography, and computed tomography in the preoperative staging of non-small-cell lung cancer: a comparison study. Ann Intern Med 1997;127:604–12.
   PubMed Web of Science ®Google Scholar
• Gornals J, Varas M, Catalá I, Maisterra S, Pons C, Bargalló D, et al. Definitive diagnosis of neuroendocrine tumors using fine-needle aspiration-puncture guided by endoscopic ultrasonography. Rev Esp Enferm Dig 2011;103:123–8.
   PubMed Web of Science ®Google Scholar
• Chatzipantelis P, Salla C, Konstantinou P, Karoumpalis I, Sakellariou S, Doumani I. Endoscopic ultrasound-guided fine-needle aspiration cytology of pancreatic neuroendocrine tumors: a study of 48 cases. Cancer 2008;114:255–62.
   PubMed Web of Science ®Google Scholar
• Chang F, Vu C, Chandra A, Meenan J, Herbert A. Endoscopic ultrasound-guided fine needle aspiration cytology of pancreatic neuroendocrine tumours: cytomorphological and immunocytochemical evaluation. Cytopathology 2006;17:10–17.
   PubMed Web of Science ®Google Scholar
• Ardengh JC, de Paulo GA, Ferrari AP. EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery. Gastrointest Endosc 2004;60:378–84.
   PubMed Web of Science ®Google Scholar
• Pais SA, Al-Haddad M, Mohamadnejad M, Leblanc JK, Sherman S, McHenry L, et al. EUS for pancreatic neuroendocrine tumors: a single-center, 11-year experience. Gastrointest Endosc 2010;71:1185–93.
   PubMed Web of Science ®Google Scholar
• Figueiredo FA, Giovannini M, Monges G, Bories E, Pesenti C, Caillol F, et al. EUS-FNA predicts 5-year survival in pancreatic endocrine tumors. Gastrointest Endosc 2009;70:907–14.
   PubMed Web of Science ®Google Scholar
• Chatzipantelis P, Konstantinou P, Kaklamanos M, Apostolou G, Salla C. The role of cytomorphology and proliferative activity in predicting biologic behavior of pancreatic neuroendocrine tumors: a study by endoscopic ultrasound-guided fine-needle aspiration cytology. Cancer 2009;117:211–16.
   PubMed Web of Science ®Google Scholar
• Larghi A, Capurso G, Carnuccio A, Ricci R, Alfieri S, Galasso D, et al. Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. Gastrointest Endosc 2012;76:570–7.
   PubMed Web of Science ®Google Scholar
• Ramage JK, Davies AH, Ardill J, Bax N, Caplin M, Grossman A, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 2005;54:iv1–16.
   PubMed Web of Science ®Google Scholar
• Kanno A, Ishida K, Hamada S, Fujishima F, Unno J, Kume K, et al. Diagnosis of autoimmune pancreatitis by EUS-FNA by using a 22-gauge needle based on the International Consensus Diagnostic Criteria. Gastrointest Endosc 2012;76:594–602.
   PubMed Web of Science ®Google Scholar
• Martin RC, Kooby DA, Weber SM, Merchant NB, Parikh AA, Cho CS, et al. Analysis of 6,747 pancreatic neuroendocrine tumors for a proposed staging system. J Gastrointest Surg 2011;15:175–83.
   PubMed Web of Science ®Google Scholar
• Lewis RB, Lattin GE Jr, Paal E. Pancreatic endocrine tumors: radiologic-clinicopathologic correlation. Radiographics 2010;30:1445–64.
   PubMed Web of Science ®Google Scholar
• Davies K, Conlon KC. Neuroendocrine tumors of the pancreas. Curr Gastroenterol Rep 2009;11:119–27.
   PubMedGoogle Scholar
• Mizuno N, Bhatia V, Hosoda W, Sawaki A, Hoki N, Hara K, et al. Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA. J Gastroenterol 2009;44:742–50.
   PubMed Web of Science ®Google Scholar
• Levy MJ, Reddy RP, Wiersema MJ, Smyrk TC, Clain JE, Harewood GC, et al. EUS-guided trucut biopsy in establishing autoimmune pancreatitis as the cause of obstructive jaundice. Gastrointest Endosc 2005;61:467–72.
   PubMed Web of Science ®Google Scholar
• Levy MJ, Wiersema MJ, Chari ST. Chronic pancreatitis: focal pancreatitis or cancer? Is there a role for FNA/biopsy? Autoimmune pancreatitis. Endoscopy 2006;38:S30–5.
   PubMed Web of Science ®Google Scholar
• Iwashita T, Yasuda I, Doi S, Ando N, Nakashima M, Adachi S, et al. Use of samples from endoscopic ultrasound-guided 19-gauge fine-needle aspiration in diagnosis of autoimmune pancreatitis. Clin Gastroenterol Hepatol 2012;10:316–22.
   PubMed Web of Science ®Google Scholar
• Binmoeller KF, Jabusch HC, Seifert H, Soehendra N. Endosonography-guided fine-needle biopsy of indurated pancreatic lesions using an automated biopsy device. Endoscopy 1997;29:384–8.
   PubMed Web of Science ®Google Scholar
• Varadarajulu S, Fraig M, Schmulewitz N, Roberts S, Wildi S, Hawes RH, et al. Comparison of EUS-guided 19-gauge Trucut needle biopsy with EUS-guided fine-needle aspiration. Endoscopy 2004;36:397–401.
   PubMed Web of Science ®Google Scholar
• Itoi T, Itokawa F, Kurihara T, Sofuni A, Tsuchiya T, Ishii K, et al. Experimental endoscopy: objective evaluation of EUS needles. Gastrointest Endosc 2009;69:509–16.
   PubMed Web of Science ®Google Scholar
• Atiq M, Bhutani MS, Bektas M, Lee JE, Gong Y, Tamm EP, et al. EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experience. Dig Dis Sci 2012;57:791–800.
   PubMed Web of Science ®Google Scholar
• Katanuma A, Maguchi H, Yane K, Hashigo S, Kin T, Kaneko M, et al. Factors predictive of adverse events associated with endoscopic ultrasound-guided fine needle aspiration of pancreatic solid lesions. Dig Dis Sci 2013;58:2093–9.
   PubMed Web of Science ®Google Scholar
• Klöppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 2004;1014:13–27.
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Itoh A, Kawashima H, Ohno E, Matsubara H, Itoh Y, et al. Usefulness of EUS combined with contrast-enhancement in the differential diagnosis of malignant versus benign and preoperative localization of pancreatic endocrine tumors. Gastrointest Endosc 2010;71:951–9.
   PubMed Web of Science ®Google Scholar
• Reid MD, Balci S, Saka B, Adsay NV. Neuroendocrine tumors of the pancreas: current concepts and controversies. Endocr Pathol 2014;25:65–79.
   PubMed Web of Science ®Google Scholar
• Hasegawa T, Yamao K, Hijioka S, Bhatia V, Mizuno N, Hara K, et al. Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors. Endoscopy 2014;46:32–8.
   PubMed Web of Science ®Google Scholar
• Duerr EM, Mizukami Y, Ng A, Xavier RJ, Kikuchi H, Deshpande V, et al. Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis. Endocr Relat Cancer 2008;15:243–56.
   PubMed Web of Science ®Google Scholar
• Nakayama Y, Wada R, Yajima N, Hakamada K, Yagihashi S. Profiling of somatostatin receptor subtype expression by quantitative PCR and correlation with clinicopathological features in pancreatic endocrine tumors. Pancreas 2010;39:1147–54.
   PubMed Web of Science ®Google Scholar
• O’Toole D, Couvelard A, Rebours V, Zappa M, Hentic O, Hammel P, et al. Molecular markers associated with response to chemotherapy in gastro-entero-pancreatic neuroendocrine tumors. Endocr Relat Cancer 2010;17:847–56.
   PubMed Web of Science ®Google Scholar
• Raymond E, Dahan L, Raoul JL, Bang YG, Borbath I, Lombard-Bohas C, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med 2011;364:501–13.
   PubMed Web of Science ®Google Scholar
• Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E, et al. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 2011;364:514–23.
   PubMed Web of Science ®Google Scholar